Showing results (61-70 of 82) with videos related to
Sort By:
Pageof 9
International Journal of Epidemiology|July 12, 2025
A Mendelian randomization study of the effect of body mass index on 52 causes of death among 125 000 Mexican adults with admixed ancestryLouisa Gnatiuc Friedrichs, Pablo Kuri-Morales, Eirini Trichia, et al.The New England Journal of Medicine|July 18, 2020
Dexamethasone in Hospitalized Patients with Covid-19, Peter Horby, Wei Shen Lim, et al.Nature Communications|November 15, 2023
Evaluation of pragmatic oxygenation measurement as a proxy for Covid-19 severityMaaike C Swets, Steven Kerr, James Scott-Brown, et al.Hypertension (Dallas, Tex. : 1979)|September 17, 2025
Blood Pressure and Mortality in Mexico City: A Mendelian Randomization StudyMichael Turner, Pablo Kuri-Morales, Jesús Alegre-Díaz, et al.The Lancet. Diabetes & Endocrinology|September 9, 2024
Sodium-glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trialsClaire Vale, Peter J Godolphin, David Fisher, et al.Kidney Medicine|June 17, 2026
Kidney Function and Mortality in Mexico: Prospective Study of 130,000 AdultsDiego Aguilar-Ramirez, Roberto Tapia-Conyer, William G Herrington, et al.The New England Journal of Medicine|October 8, 2020
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19, Peter Horby, Marion Mafham, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 2, 2025
Effects of Empagliflozin on Urine Biomarkers in EMPA-KIDNEYGreco B Malijan, Rebecca J Sardell, Natalie Staplin, et al.JAMA|November 7, 2025
Effects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Status and Level of Albuminuria: A Meta-AnalysisNatalie Staplin, Alistair J Roddick, Brendon L Neuen, et al.Journal of the American Society of Nephrology : JASN|December 12, 2023
Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKDKaitlin J Mayne, Natalie Staplin, David F Keane, et al.Pageof 9